Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
07 Novembre 2023 - 2:00PM
Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it
will participate in an analyst-led fireside chat at the following
two healthcare conferences:
- Jefferies London Healthcare Conference
on Tuesday, November 14th at 11:00AM GMT (6:00AM ET).
- 35th Annual Piper Sandler Healthcare Conference on Tuesday,
November 28th at 2:00PM ET.
Live audio of the events can be accessed by visiting the
“Events” page of the company’s website at investor.pacira.com. A
replay of the webcasts will also be available for two weeks
following the events.
About Pacira
Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to
providing a non-opioid option to as many patients as possible to
redefine the role of opioids as rescue therapy only. The company is
also developing innovative interventions to address debilitating
conditions involving the sympathetic nervous system, such as
cardiac electrical storm, chronic pain, and spasticity. Pacira has
three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine
liposome injectable suspension), a long-acting, local analgesia
currently approved for postsurgical pain management; ZILRETTA®
(triamcinolone acetonide extended-release injectable suspension),
an extended-release, intra-articular, injection indicated for the
management of osteoarthritis knee pain; and ioveraº®, a novel,
handheld device for delivering immediate, long-acting, drug-free
pain control using precise, controlled doses of cold temperature to
a targeted nerve. To learn more about Pacira, including the
corporate mission to reduce overreliance on opioids, visit
www.pacira.com.
Company Contact:
Pacira BioSciences, Inc.
Christian Pedetti
(973) 254-4387
Christian.pedetti@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Pacira BioSciences (NASDAQ:PCRX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024